Zenocutuzumab (Anti-HER2 & HER3)
Product Specifications
CAS Number
1969309-56-5
Synonyms
MCLA-128, PB4188, R040517
Target
HER2
Applications
Protein Tyrosine Kinase
Additionnal Information
Zenocutuzumab is a humanized bispecific IgG1 antibody targeting HER2 and HER3 to enhance antibody-dependent cellular cytotoxicity (ADCC) and inhibit tumor growth. It is being developed for the treatment of cancers overexpressing HER2 and HER3, leveraging dual targeting for enhanced antitumor activity. M. W 145.88 kDa
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740276-100 1x 100 µL
TAG-72 / CA72.4 (B72.3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940383-100 1x 100 µL
Cytokeratin 8 (K8/383), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472250-500 1x 500 µL
Squamous Cell Carcinoma Antigen 1 (CPTC-SERPINB3-2), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040782-500 1x 500 µL
Bcl-2 (BCL2/782), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details